Literature DB >> 1466052

Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions.

J Huard1, R Roy, J P Bouchard, F Malouin, C L Richards, J P Tremblay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466052

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  27 in total

Review 1.  Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions.

Authors:  Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

Review 2.  Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Authors:  Jane T Seto; Julian N Ramos; Lindsey Muir; Jeffrey S Chamberlain; Guy L Odom
Journal:  Curr Gene Ther       Date:  2012-06       Impact factor: 4.391

3.  Long-term survival of transplanted stem cells in immunocompetent mice with muscular dystrophy.

Authors:  Gregory Q Wallace; Karen A Lapidos; Jordan S Kenik; Elizabeth M McNally
Journal:  Am J Pathol       Date:  2008-08-18       Impact factor: 4.307

4.  Building immune tolerance through DNA vaccination.

Authors:  Robin J Parks; Emanuela Gussoni
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-06       Impact factor: 11.205

5.  Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts.

Authors:  A Irintchev; M Langer; M Zweyer; R Theisen; A Wernig
Journal:  J Physiol       Date:  1997-05-01       Impact factor: 5.182

Review 6.  Gene therapy in large animal models of muscular dystrophy.

Authors:  Zejing Wang; Jeffrey S Chamberlain; Stephen J Tapscott; Rainer Storb
Journal:  ILAR J       Date:  2009

7.  Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.

Authors:  Guy L Odom; Paul Gregorevic; James M Allen; Eric Finn; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

Review 8.  Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells.

Authors:  Francesco Saverio Tedesco; Arianna Dellavalle; Jordi Diaz-Manera; Graziella Messina; Giulio Cossu
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

9.  Prosurvival Factors Improve Functional Engraftment of Myogenically Converted Dermal Cells into Dystrophic Skeletal Muscle.

Authors:  Lindsey A Muir; Charles E Murry; Jeffrey S Chamberlain
Journal:  Stem Cells Dev       Date:  2016-09-07       Impact factor: 3.272

10.  Functional effects of myoblast implantation into histoincompatible mice with or without immunosuppression.

Authors:  A Wernig; A Irintchev; G Lange
Journal:  J Physiol       Date:  1995-04-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.